CD274 and neoplasm: They further showed that the antitumor response is due to the regulation of antitumor immunity and augmented by treatment with anti-programmed cell death protein 1 ligand 1 mAb (anti-PD-L1)—an effect that was mediated by enhanced CD8+ T cell priming and accumulation in the tumor microenvironment [43].